摘要:
17-Aryl and 17-heterocyclyl-5β,14β-androstane derivatives of general formula (I):
wherein:
the symbol means that the substituents in position 17 can have an a or configuration; the symbol represents a single or a double bond; Y, R and R 1 have the meanings given in the description; a process for producing same, pharmaceutical compositions containing same as active ingredient, and their use in the preparation of a pharmaceutical agent for the treatment of cardiovascular disorders such as heart failure and hypertension are disclosed.
摘要:
6-Hydroxy and 6-oxo-androstane derivatives having the general formula (I): wherein the symbol represents a single or a double bond and A, R 1 and R 2 have the meanings given in the description; a pharmaceutical composition comprising the same and their use for the preparation of a medicament useful for the treatment of cardiovascular disorders such as heart failure and hypertension are disclosed.
摘要:
14-Deoxy-14a -cardenolides 3β-thioderivatives and pharmaceutical compositions comprising same for treating cardiovascular disorders, such as heart failure and hypertension are disclosed.
摘要:
Digitoxigenin and dihydrodigitoxigenin 3β-derivatives, a process for their preparation and pharmaceutical compositions containing same for the treatment of cardiovascular disorders such as heart failure and hypertension are disclosed.
摘要:
17-Aryl and 17-heterocyclyl-5β,14β-androstane derivatives of general formula (I): wherein: the symbol means that the substituents in position 17 can have an a or configuration; the symbol represents a single or a double bond; Y, R and R 1 have the meanings given in the description; a process for producing same, pharmaceutical compositions containing same as active ingredient, and their use in the preparation of a pharmaceutical agent for the treatment of cardiovascular disorders such as heart failure and hypertension are disclosed.
摘要:
17-(3-Furyl) and (4-pyridazinyl)-5β,14β-androstane derivatives of formula (I)
wherein the symbol the symbol --- , Y, R, R 1 , R 2 and R 3 have the meaning indicated in the specification. Processes of making the said compounds and pharmaceutical compositions containing them are also disclosed.
摘要:
3,9-disubstituted-spiro[5.5]undecanes of formula (I): wherein R represents hydrogen or an unsubstituted or substituted C2-C6 alkyl or C2-C6 alkenyl group, n is an integer from 0 to 4 and Y is oxygen or sulphur; and the symbol means a single or double bond with the proviso that (i) when is a single bond A: represents a C-H or C-OR¹ group, wherein R¹ is H or CH3, and; B: represents a substituted C1-C6 lower alkyl or C2-C6 alkenyl chain; (ii) when is a double bond A: represents a carbon atom C and; B: represents: a = N-NR²-C(=Z)NHR³ group, wherein R² and R³ are hydrogen, C1-C6 lower alkyl, benzyl or phenyl, or R² and R³, taken together with the nitrogen atoms, form an unsubstituted or substituted 5- or 6-membered ring, and Z is oxygen, sulphur or NR , wherein R is H, C1-C4 lower alkyl, CN or taken together with R² or R³ forms an unsubstituted or substituted monoheterocyclic 5- or 6-membered ring; and their pharmaceutically acceptable salts. These compounds may be used for the preparation of a medicament for the treatment of cardiovascular disorders, hypertension and/or cardiac failure.